BRPI0409009A - compostos cristalinos de n-formila hidroxilamina - Google Patents

compostos cristalinos de n-formila hidroxilamina

Info

Publication number
BRPI0409009A
BRPI0409009A BRPI0409009-8A BRPI0409009A BRPI0409009A BR PI0409009 A BRPI0409009 A BR PI0409009A BR PI0409009 A BRPI0409009 A BR PI0409009A BR PI0409009 A BRPI0409009 A BR PI0409009A
Authority
BR
Brazil
Prior art keywords
formyl hydroxylamine
compounds
alkanes
crystalline compounds
crystalline
Prior art date
Application number
BRPI0409009-8A
Other languages
English (en)
Portuguese (pt)
Inventor
Hui Liu
Joginder Singh Bajwa
Joel Slade
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33131903&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0409009(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BRPI0409009A publication Critical patent/BRPI0409009A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
BRPI0409009-8A 2003-04-02 2004-04-01 compostos cristalinos de n-formila hidroxilamina BRPI0409009A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45972603P 2003-04-02 2003-04-02
PCT/EP2004/003478 WO2004087133A1 (en) 2003-04-02 2004-04-01 Crystalline n-formyl hydroxylamine compounds

Publications (1)

Publication Number Publication Date
BRPI0409009A true BRPI0409009A (pt) 2006-03-28

Family

ID=33131903

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0409009-8A BRPI0409009A (pt) 2003-04-02 2004-04-01 compostos cristalinos de n-formila hidroxilamina

Country Status (25)

Country Link
US (1) US20070135353A1 (https=)
EP (1) EP1613305A1 (https=)
JP (1) JP2006522054A (https=)
KR (1) KR20060002915A (https=)
CN (1) CN1764450A (https=)
AR (1) AR043804A1 (https=)
AU (1) AU2004226815B2 (https=)
BR (1) BRPI0409009A (https=)
CA (1) CA2520682A1 (https=)
CL (1) CL2004000705A1 (https=)
CO (1) CO5630028A2 (https=)
EC (1) ECSP056043A (https=)
IS (1) IS8093A (https=)
MA (1) MA27763A1 (https=)
MX (1) MXPA05010610A (https=)
MY (1) MY136854A (https=)
NO (1) NO20055097L (https=)
NZ (1) NZ542432A (https=)
PE (1) PE20050392A1 (https=)
RU (1) RU2005133660A (https=)
SG (1) SG166681A1 (https=)
TN (1) TNSN05248A1 (https=)
TW (1) TW200427458A (https=)
WO (1) WO2004087133A1 (https=)
ZA (1) ZA200507179B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1406893B1 (en) 2001-06-15 2007-04-18 Vicuron Pharmaceuticals, Inc. Pyrrolidine bicyclic compounds
ATE417826T1 (de) 2002-09-19 2009-01-15 Novartis Pharma Gmbh Verfahren zur herstellung von zwischenprodukten
MXPA05008842A (es) 2003-02-21 2005-10-05 Novartis Ag Proceso quimico.
GT200600196A (es) * 2005-05-23 2007-01-15 Compuestos n-formil de hidroxilamina
JP7001898B2 (ja) * 2016-05-11 2022-01-20 グアンドン・ヘボ・ファーマシューティカル・カンパニー・リミテッド スピロ3員環、スピロ5員環系ペプチドデホルミラーゼ阻害剤および抗菌と抗腫瘍におけるその使用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3282986A (en) * 1960-10-06 1966-11-01 Merck & Co Inc N-acylated hydroxamic acids and derivatives thereof
DK1052984T3 (da) * 1998-02-07 2004-09-20 Vernalis Oxford Ltd Antibakterielle midler
AR036053A1 (es) * 2001-06-15 2004-08-04 Versicor Inc Compuestos de n-formil-hidroxilamina, un proceso para su preparacion y composiciones farmaceuticas

Also Published As

Publication number Publication date
NO20055097L (no) 2005-12-22
CA2520682A1 (en) 2004-10-14
US20070135353A1 (en) 2007-06-14
RU2005133660A (ru) 2006-06-10
AU2004226815B2 (en) 2007-07-19
NZ542432A (en) 2009-04-30
PE20050392A1 (es) 2005-06-19
TNSN05248A1 (en) 2007-06-11
MXPA05010610A (es) 2005-11-23
IS8093A (is) 2005-10-27
AU2004226815A1 (en) 2004-10-14
CO5630028A2 (es) 2006-04-28
SG166681A1 (en) 2010-12-29
CL2004000705A1 (es) 2005-01-14
WO2004087133A1 (en) 2004-10-14
MA27763A1 (fr) 2006-02-01
MY136854A (en) 2008-11-28
ZA200507179B (en) 2006-04-26
NO20055097D0 (no) 2005-11-01
KR20060002915A (ko) 2006-01-09
ECSP056043A (es) 2006-01-27
JP2006522054A (ja) 2006-09-28
TW200427458A (en) 2004-12-16
EP1613305A1 (en) 2006-01-11
AR043804A1 (es) 2005-08-10
CN1764450A (zh) 2006-04-26

Similar Documents

Publication Publication Date Title
WO2008142055A3 (en) Antiviral agents
BRPI0412488A (pt) derivados de heteroarila e arila trissubstituìdas poro moduladores de metabolismo e a profilaxia e tratamento de distúrbios relacionados a este
BRPI0512060A (pt) compostos orgánicos
BRPI0406926A (pt) Inibidores de polimerase viral
BRPI0412763A (pt) formas anidras, hidratadas ou solvatadas de um composto, forma cristalina, composição farmacêutica, e, método para o tratamento ou a profilaxia de distúrbios
BRPI0415960A (pt) composto ou um sal do mesmo, pró-droga de um composto, agente farmacêutico, inibidor de peptidase, composto ou um sal do mesmo, pró-droga de um composto, agente farmacêutico, inibidor de peptidase, uso de um composto,e, método para produzir um composto
NZ593111A (en) Antibacterial compounds
DK2203430T3 (da) N-phenyl-dioxo-hydropyrimidiner anvendelige som inhibitorer for hepatitis C virus (HCV)
BRPI0809977A8 (pt) Uso de um composto, compostos e composição farmacêutica que o contém
EA201290089A1 (ru) Химические соединения
EA201290397A1 (ru) 1,3,4-оксадиазол-2-карбоксамидное соединение
GT200800170A (es) Compuestos de n-formil-hidroxilamina
MY146923A (en) Novel piperazine compound, and use thereof as hcv polymerase inhibitor
NO20075270L (no) Antibakterielle amid-makrocykler V
ATE540667T1 (de) Verbindungen mit kühlender wirkung
DE60333746D1 (de) Thienylverbindungen
NO20074251L (no) Nye isotiazolokinoloner of relaterte forbindelser som anti-infektive midler
BRPI0515851A (pt) composto de pirimidona
EA200800444A1 (ru) 8-МЕТОКСИ-9Н-ИЗОТИАЗОЛО[5,4-b]ХИНОЛИН-3,4-ДИОНЫ И РОДСТВЕННЫЕ СОЕДИНЕНИЯ В КАЧЕСТВЕ ПРОТИВОИНФЕКЦИОННЫХ СРЕДСТВ
NO20092655L (no) 2-kinolinon- og 2-kinoksalinonderivater og deres anvendelse som antibakterielle midler
MXPA05009688A (es) Derivados de naftiridina como agentes antibacterianos.
BRPI0409009A (pt) compostos cristalinos de n-formila hidroxilamina
UA96149C2 (en) Method for producing 4-oxoquinoline compound
WO2009008920A3 (en) Hydroxamic acid derivatives of 4-phenyl 4-hydroxy, 4-phenyl 4-alkoxy and 4-phenyl 4-arylalkoxy butyric acid useful as therapeutic agents for treating anthrax poisoning
TW200801011A (en) New compounds II

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012.